- Home
- PCLA vs LVTX Comparison
PCLA vs LVTX Comparison
Compare PCLA & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCLA
- LVTX
- Stock Information
- Founded
- PCLA 2008
- LVTX 2016
- Country
- PCLA Japan
- LVTX Netherlands
- Employees
- PCLA N/A
- LVTX N/A
- Industry
- PCLA Building Products
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- PCLA Consumer Discretionary
- LVTX Health Care
- Exchange
- PCLA Nasdaq
- LVTX Nasdaq
- Market Cap
- PCLA 32.3M
- LVTX 34.2M
- IPO Year
- PCLA 2025
- LVTX 2021
- Fundamental
- Price
- PCLA $0.55
- LVTX $1.31
- Analyst Decision
- PCLA
- LVTX Hold
- Analyst Count
- PCLA 0
- LVTX 3
- Target Price
- PCLA N/A
- LVTX $3.17
- AVG Volume (30 Days)
- PCLA 119.3K
- LVTX 61.1K
- Earning Date
- PCLA 01-01-0001
- LVTX 05-20-2025
- Dividend Yield
- PCLA N/A
- LVTX N/A
- EPS Growth
- PCLA N/A
- LVTX N/A
- EPS
- PCLA N/A
- LVTX N/A
- Revenue
- PCLA $5,475,228.00
- LVTX $11,982,000.00
- Revenue This Year
- PCLA N/A
- LVTX N/A
- Revenue Next Year
- PCLA N/A
- LVTX N/A
- P/E Ratio
- PCLA N/A
- LVTX N/A
- Revenue Growth
- PCLA 40.19
- LVTX 77.01
- 52 Week Low
- PCLA $0.46
- LVTX $0.85
- 52 Week High
- PCLA $9.80
- LVTX $3.20
- Technical
- Relative Strength Index (RSI)
- PCLA N/A
- LVTX 61.39
- Support Level
- PCLA N/A
- LVTX $1.03
- Resistance Level
- PCLA N/A
- LVTX $1.20
- Average True Range (ATR)
- PCLA 0.00
- LVTX 0.08
- MACD
- PCLA 0.00
- LVTX 0.00
- Stochastic Oscillator
- PCLA 0.00
- LVTX 87.50
About PCLA PicoCELA Inc. American Depositary Shares
PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.